Winona is a telehealth company delivering doctor-prescribed bioidentical hormone replacement therapy for menopause care across 35 US states via a vertically integrated model.
Winona is a telehealth company that provides menopause care through doctor-prescribed, bioidentical hormone replacement therapy delivered to patients' doors. Founded in 2021 and operating across 35 states in the United States, the company serves more than 100,000 women and reports 300% year-over-year growth. Its telehealth platform connects patients with board-certified physicians for care spanning perimenopause through post-menopause, supporting roughly 25,000 monthly active subscribers.
The company runs a fully vertically integrated model. Alongside its telehealth care platform, Winona operates two compounding pharmacies, which supply the bioidentical hormone replacement therapy it prescribes. Technical work spans telehealth technology, compounding pharmacy operations and hormone therapy, supported by a team of board-certified physicians and compounding pharmacy staff; exact headcount has not been disclosed.
Winona also runs a member community of 16,000 engaged members, focused on education and support through the menopause journey. The company describes itself as built by women for women, combining telehealth technology with personalised care. Funding details have not been disclosed.
